Literature DB >> 28031220

Pathological ponto-cerebello-thalamo-cortical activations in primary orthostatic tremor during lying and stance.

Florian Schöberl1,2, Katharina Feil1,2, Guoming Xiong2, Peter Bartenstein2,3,4, Christian la Fougére2,5, Klaus Jahn2,6, Thomas Brandt2,7, Michael Strupp1,2, Marianne Dieterich1,2,4, Andreas Zwergal8,2.   

Abstract

Primary orthostatic tremor is a rare neurological disease characterized mainly by a high frequency tremor of the legs while standing. The aim of this study was to identify the common core structures of the oscillatory circuit in orthostatic tremor and how it is modulated by changes of body position. Ten patients with orthostatic tremor and 10 healthy age-matched control subjects underwent a standardized neurological and neuro-ophthalmological examination including electromyographic and posturographic recordings. Task-dependent changes of cerebral glucose metabolism during lying and standing were measured in all subjects by sequential 18F-fluorodeoxyglucose-positron emission tomography on separate days. Results were compared between groups and conditions. All the orthostatic tremor patients, but no control subject, showed the characteristic 13-18 Hz tremor in coherent muscles during standing, which ceased in the supine position. While lying, patients had a significantly increased regional cerebral glucose metabolism in the pontine tegmentum, the posterior cerebellum (including the dentate nuclei), the ventral intermediate and ventral posterolateral nucleus of the thalamus, and the primary motor cortex bilaterally compared to controls. Similar glucose metabolism changes occurred with clinical manifestation of the tremor during standing. The glucose metabolism was relatively decreased in mesiofrontal cortical areas (i.e. the medial prefrontal cortex, supplementary motor area and anterior cingulate cortex) and the bilateral anterior insula in orthostatic tremor patients while lying and standing. The mesiofrontal hypometabolism correlated with increased body sway in posturography. This study confirms and further elucidates ponto-cerebello-thalamo-primary motor cortical activations underlying primary orthostatic tremor, which presented consistently in a group of patients. Compared to other tremor disorders one characteristic feature in orthostatic tremor seems to be the involvement of the pontine tegmentum in the pathophysiology of tremor generation. High frequency oscillatory properties of pontine tegmental neurons have been reported in pathological oscillatory eye movements. It is remarkable that the characteristic activation and deactivation pattern in orthostatic tremor is already present in the supine position without tremor presentation. Multilevel changes of neuronal excitability during upright stance may trigger activation of the orthostatic tremor network. Based on the functional imaging data described in this study, it is hypothesized that a mesiofrontal deactivation is another characteristic feature of orthostatic tremor and plays a pivotal role in development of postural unsteadiness during prolonged standing.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  PET; cerebellum; imaging; orthostatic tremor; pons

Mesh:

Year:  2017        PMID: 28031220     DOI: 10.1093/brain/aww268

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  17 in total

1.  Orthostatic tremor and behavioral frontotemporal dementia: a case report with 7 years of follow-up.

Authors:  Gianna Santus; Sofia Faletti; Domenico De Grandis
Journal:  Neurol Sci       Date:  2019-05-25       Impact factor: 3.307

2.  Mental calculation increases physiological postural tremor, but does not influence physiological goal-directed kinetic tremor.

Authors:  Francesco Budini; Richard Mocnik; Markus Tilp; Domenico Crognale
Journal:  Eur J Appl Physiol       Date:  2022-09-19       Impact factor: 3.346

Review 3.  Orthostatic Tremor: Pathophysiology Guiding Treatment.

Authors:  David Whitney; Danish Bhatti; Diego Torres-Russotto
Journal:  Curr Treat Options Neurol       Date:  2018-07-21       Impact factor: 3.598

4.  Proprioceptive muscle tendon stimulation reduces symptoms in primary orthostatic tremor.

Authors:  M Wuehr; C Schlick; K Möhwald; R Schniepp
Journal:  J Neurol       Date:  2018-05-16       Impact factor: 4.849

Review 5.  Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria.

Authors:  Hyun Ah Kim; Alexandre Bisdorff; Adolfo M Bronstein; Thomas Lempert; Marcos Rossi-Izquierdo; Jeffrey P Staab; Michael Strupp; Ji-Soo Kim
Journal:  J Vestib Res       Date:  2019       Impact factor: 2.354

Review 6.  Pathogenesis of Primary Orthostatic Tremor: Current Concepts and Controversies.

Authors:  Abhishek Lenka; Pramod Kumar Pal; Danish Ejaz Bhatti; Elan D Louis
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-11-17

7.  Complete Resolution of Symptoms of Primary Orthostatic Tremor with Perampanel.

Authors:  María Ruiz-Julián; Jorge Luís Orozco; Alexandre Gironell
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-04-17

8.  Walking in orthostatic tremor modulates tremor features and is characterized by impaired gait stability.

Authors:  M Wuehr; C Schlick; K Möhwald; R Schniepp
Journal:  Sci Rep       Date:  2018-09-20       Impact factor: 4.379

9.  A Rare Presentation of Orthostatic Tremor as Abdominal Tremor.

Authors:  Christina Mousele; Paul Bentley; Yen F Tai
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-12-04

10.  Health-Related Quality of Life Is Severely Affected in Primary Orthostatic Tremor.

Authors:  Lucie Maugest; Eavan M McGovern; Katia Mazalovic; Mohamed Doulazmi; Emmanuelle Apartis; Mathieu Anheim; Frédéric Bourdain; Eve Benchetrit; Virginie Czernecki; Emmanuel Broussolle; Cecilia Bonnet; Bruno Falissard; Marjan Jahanshahi; Marie Vidailhet; Emmanuel Roze
Journal:  Front Neurol       Date:  2018-01-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.